Human Identification Market is Expected to Reach $1.3 billion | MarketsandMarkets™
May 03, 2024 08:30 ET
|
MarketsandMarkets Research Pvt. Ltd.
Chicago, May 03, 2024 (GLOBE NEWSWIRE) -- Human Identification market in terms of revenue was estimated to be worth $0.8 billion in 2024 and is poised to reach $1.3 billion by 2029, growing at a...
Ocuphire Pharma to Present at the Aegis Virtual Conference
May 03, 2024 08:00 ET
|
Ocuphire Pharma
FARMINGTON HILLS, Mich., May 03, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of...
Immuron Director Resignation
May 03, 2024 06:00 ET
|
Immuron Limited
MELBOURNE, Australia, May 03, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, advises that Stephen...
Invivyd to Host Conference Call Discussing First Quarter 2024 Financial Results and Business Highlights
May 02, 2024 17:13 ET
|
Invivyd
WALTHAM, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced...
Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting
May 02, 2024 17:00 ET
|
Tenaya Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver...
ClearPoint Neuro to Present Novel Research and Exhibit at the 27th American Society of Gene & Cell Therapy Annual Meeting in Baltimore
May 02, 2024 16:05 ET
|
ClearPoint Neuro, Inc.
Novel drug delivery research to be presented by ClearPoint Neuro Biologics team at ASGCT 2024 Annual Meeting in Baltimore
OrthoPediatrics Corp. Receives “Breakthrough Device” Designation from FDA for eLLi™ Growing Rod System for Pediatric Patients with Scoliosis
May 02, 2024 16:05 ET
|
OrthoPediatrics Corp.
WARSAW, Ind., May 02, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today...
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update
May 02, 2024 16:01 ET
|
Xenon Pharmaceuticals Inc.
VANCOUVER, British Columbia, May 02, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced it will report its first...
Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors
May 02, 2024 16:01 ET
|
Vor Biopharma
CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced the appointment of Fouad Namouni, M.D., to its Board...
Novotech, 낭포성 섬유증 임상시험 환경에 대한 분석 보고서 발간하며 바이오텍 연구 계획에 대한 최신 정보 제공
May 02, 2024 15:35 ET
|
Novotech
보스턴, May 03, 2024 (GLOBE NEWSWIRE) -- 바이오텍과의 파트너십을 통해 임상시험 모든 단계에서 혁신적이고 새로운 치료제 개발을 가속하는데 주력하는 글로벌 풀서비스 임상시험수탁기관(CRO)인 노보텍(Novotech)이 Cystic Fibrosis - Global Clinical Trial Landscape (낭포성 섬유증 -...